| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10856-012-4818-9 |
| P698 | PubMed publication ID | 23160914 |
| P50 | author | João F. Mano | Q39438017 |
| José Luis Gómez Ribelles | Q51045166 | ||
| Jorge Luis Escobar Ivirico | Q63991585 | ||
| P2093 | author name string | D M García Cruz | |
| V Sardinha | |||
| P2860 | cites work | Expression of collagen type I, II, X and Ki-67 in osteochondroma compared to human growth plate cartilage | Q78628804 |
| Response of human chondrocytes to a non-uniform distribution of hydrophilic domains on poly (ethyl acrylate-co-hydroxyethyl methacrylate) copolymers | Q81123700 | ||
| Cartilage regeneration using adipose-derived stem cells and the controlled-released hybrid microspheres | Q82294593 | ||
| In vivo evaluation of 3-dimensional polycaprolactone scaffolds for cartilage repair in rabbits | Q82607220 | ||
| Preparation and properties of an injectable scaffold of poly(lactic-co-glycolic acid) microparticles/chitosan hydrogel | Q84283027 | ||
| In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells | Q33635879 | ||
| Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. | Q34242267 | ||
| In situ crosslinkable hyaluronan hydrogels for tissue engineering | Q34279584 | ||
| Gelatin microspheres crosslinked with genipin for local delivery of growth factors | Q34282125 | ||
| Silk hydrogel for cartilage tissue engineering | Q34813808 | ||
| Articular cartilage engineering with autologous chondrocyte transplantation. A review of recent developments. | Q35202437 | ||
| Engineered cartilage via self-assembled hMSC sheets with incorporated biodegradable gelatin microspheres releasing transforming growth factor-β1. | Q35803509 | ||
| A clinical review of cartilage repair techniques. | Q36082320 | ||
| Polymer-based microparticles in tissue engineering and regenerative medicine | Q37876388 | ||
| The tissue engineering of articular cartilage: cells, scaffolds and stimulating factors. | Q37966642 | ||
| Genipin enhances the mechanical properties of tissue-engineered cartilage and protects against inflammatory degradation when used as a medium supplement | Q39277177 | ||
| Cytocompatibility study of a natural biomaterial crosslinker--Genipin with therapeutic model cells | Q39580289 | ||
| In vitro evaluation of cytotoxicity of diepoxy compounds used for biomaterial modification | Q41331334 | ||
| Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. | Q42740469 | ||
| Tissue-engineered cartilage of porcine and human origin as in vitro test system in arthritis research | Q43122345 | ||
| Chitosan/polyester-based scaffolds for cartilage tissue engineering: assessment of extracellular matrix formation | Q43269610 | ||
| Controlled release of growth factors based on biodegradation of gelatin hydrogel | Q43595834 | ||
| Expansion of human nasal chondrocytes on macroporous microcarriers enhances redifferentiation | Q44025187 | ||
| Human articular chondrocytes on macroporous gelatin microcarriers form structurally stable constructs with blood-derived biological glues in vitro. | Q44404198 | ||
| Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms | Q44885788 | ||
| Formulation of PEG-based hydrogels affects tissue-engineered cartilage construct characteristics | Q45044698 | ||
| Rapid phenotypic changes in passaged articular chondrocyte subpopulations | Q45284833 | ||
| Preparation of resorbable collagen-based beads for direct use in tissue engineering and cell therapy applications. | Q45906014 | ||
| Chitosan microparticles as injectable scaffolds for tissue engineering | Q46491849 | ||
| Controlled release of bioactive transforming growth factor beta-1 from fibrin gels in vitro | Q46547836 | ||
| Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications | Q46603410 | ||
| Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair | Q46724045 | ||
| Gelatin microspheres containing TGF-beta3 enhance the chondrogenesis of mesenchymal stem cells in modified pellet culture. | Q47918285 | ||
| In situ gelling hydrogels incorporating microparticles as drug delivery carriers for regenerative medicine | Q47945759 | ||
| Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate-modified hydrogels. | Q51129950 | ||
| Porous gelatin-chondroitin-hyaluronate tri-copolymer scaffold containing microspheres loaded with TGF-beta1 induces differentiation of mesenchymal stem cells in vivo for enhancing cartilage repair. | Q51237177 | ||
| Presence and distribution of collagen II, collagen I, fibronectin, and tenascin in rabbit normal and osteoarthritic cartilage. | Q52980628 | ||
| Injectable in situ crosslinkable RGD-modified alginate matrix for endothelial cells delivery | Q62060654 | ||
| Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering | Q77460826 | ||
| P433 | issue | 2 | |
| P921 | main subject | cartilage | Q502730 |
| P304 | page(s) | 503-513 | |
| P577 | publication date | 2012-11-18 | |
| P1433 | published in | Journal of Materials Science: Materials in Medicine | Q6295496 |
| P1476 | title | Gelatin microparticles aggregates as three-dimensional scaffolding system in cartilage engineering | |
| P478 | volume | 24 |
| Q51121664 | Cellular Self-Assembly with Microsphere Incorporation for Growth Factor Delivery Within Engineered Vascular Tissue Rings. |
| Q51065635 | Mathematical modelling of glycosaminoglycan production by stem cell aggregates incorporated with growth factor-releasing polymer microspheres. |
| Q38369781 | PCL-TCP wet spun scaffolds carrying antibiotic-loaded microspheres for bone tissue engineering. |
| Q90406559 | Past, present, and future of microcarrier-based tissue engineering |
| Q57170868 | Processing of Biomedical Devices for Tissue Engineering and Regenerative Medicine Applications |
| Q59813525 | Targeted Delivery of Bioactive Molecules for Vascular Intervention and Tissue Engineering |
Search more.